Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT+ Cancers

Kathryn G. Roberts(St. Jude Children's Research Hospital), Nicole M. Verrills(Hunter Medical Research Institute)
Cancer Research
June 15, 2010
10.1158/0008-5472.can-09-2544
Cited by 130

Related Papers

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
|Nature|2012|1.6k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|616
The genomic landscape of pediatric acute lymphoblastic leukemia
|Nature Genetics|2022|394
Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults
|Blood|2016|385